Rosiglitazone Improves Learning and Memory Ability in Rats with Type 2 Diabetes Through the Insulin Signaling Pathway

American Journal of the Medical Sciences

Volumn 350, Issue 2, 2015, Pages 121-128

  Ma, Lina ^a,b   Shao, Zhimin ^a   Wang, Rong ^a   Zhao, Zhiwei ^a   Dong, Wen ^a   Zhang, Jingshuang ^a   Zhang, Xu ^a   Sheng, Shuli ^a   Ji, Zhijuan ^a   Zhang, Jingyan ^a  

^a BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic encephalopathy; Insulin signal transduction; Rosiglitazone; Type 2 diabetes mellitus

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN BCL 2; PROTEIN KINASE B; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPRAGUE DAWLEY RAT; TASK PERFORMANCE; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HIPPOCAMPUS; INSULIN; LEARNING; MALE; MEMORY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 84938683644     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000499     Document Type: Conference Paper

References (42)

1. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882-91.
2. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48:2460-9.
3. Biessels GJ, van der Heide LP, Kamal A, et al. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14.
4. Yamamoto KT, Miyoshi T, Yea K, et al. The survival of rat cerebral cortical neurons in the presence of trophic APP peptide. J Neurobiol 1994;25:585-94.
5. Han X, Ma Y, Liu X, et al. Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model. J Neural Transm 2012;119:1407-16.
6. Pasquier F, Boulogne A, Leys D, et al. Diabetes mellitus and dementia. Diabetes Metab 2006;32:403-14.
7. Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol 2013;1:164-5.
8. Kavak S, Ayaz L, Emre M, et al. The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats. Cell Biochem Funct 2008;26:478-85.
9. Inestrosa NC, Godoy JA, Quintanilla RA, et al. Peroxisome proliferator-activated receptor g is expressed in hippocampal neurons and its activation prevents b-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 2005;304:91-104.
10. Combs CK, Johnson DE, Karlo JC, et al. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 2000;20:558-67.
11. Sastre M, Dewachter I, Landreth GE, et al. Nonsteroidal antiinflammatory drugs and peroxisome proliferator-activated receptorgamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci 2003;23:9796-804.
12. Zeng G, Nystrom FH, Ravichandran LV, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-45.
13. Watson GS, Cholerton BA, Reger MA, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005;13:950-8.
14. Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972; 48:422-7.
15. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012;12:159-69.
16. Rodriguez-Araujo G, Nakagami H, Hayashi H, et al. Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway. Cell Mol Life Sci 2013;70:1123-33.
17. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997;29:691-9.
18. de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetesevidence reviewed. J Diabetes Sci Technol 2008;2:1101-13.
19. Banks WA, Owen JB, Erickson MA, et al. Insulin in the brain: there and back again. Pharmacol Ther 2012;136:82-93.
20. Luisi P, Alvarez-Ponce D, Dall'Olio GM, et al. Network-level and population genetics analysis of the insulin/TOR signal transduction pathway across human populations. Mol Biol Evol 2012;29:1379-92.
21. Kanazawa T, Taneike I, Akaishi R, et al. Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem 2004;279: 8452-9.
22. Maher F, Davies-Hill TM, Lysko PG, et al. Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3. Mol Cell Neurosci 1991;2:351-60.
23. Leinninger GM, Backus C, Uhler MD, et al. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J 2004;18:1544-6.
24. Chin PC, Majdzadeh N, D'Mello SR. Inhibition of GSK3b is a common event in neuroprotection by different survival factors. Mol Brain Res 2005;137:193-201.
25. Schubert M, Gautam D, Surjo D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 2004;101:3100-5.
26. Young JE, Martinez RA, La Spada AR. Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation. J Biol Chem 2009;284:2363-73.
27. Giuffrida ML, Tomasello F, Caraci F, et al. Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease. Mol Neurobiol 2012;46:605-13.
28. Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 2005;7:63-80.
29. Son SM, Jung ES, Shin HJ, et al. Ab-induced formation of autophagosomes is mediated by RAGE-CaMKKb-AMPK signaling. Neurobiol Aging 2012;33:11-23.
30. Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011;10:1784-93.
31. Zhou J, Zhou S, Tang J, et al. Protective effect of berberine on beta cells in streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 2009;606:262-8.
32. Watson GS, Craft S. The role of insulin-resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 2003;17:27-45.
33. Sheu WH, Chuang HC, Cheng SM, et al. Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia. J Pharm Biomed Anal 2011;54:759-64.
34. Noppamas P, Wasana P, Nipon C, et al. PPAR,gamma. Agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 2012;153:329-38.
35. Brodbeck J, Balestra ME, Saunders AM, et al. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A 2008;105:1343-6.
36. Jolivalt CG, Lee CA, Beiswenger KK, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 2008;86:3265-74.
37. Pedersen WA, McMillan PJ, Kulstad JJ, et al. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 2006;199:265-73.
38. Pedersen WA, Flynn ER. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 2004;17:500-6.
39. Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012;2012: 384017.
40. Duarte AI, Santos P, Oliveira CR, et al. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3b signaling pathways and changes in protein expression. Biochim Biophys Acta 2008; 1783:994-1002.
41. Duarte AI, Proença T, Oliveira CR, et al. Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 2006;55:2863-70.
42. Gerozissis K. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 2003;23:1-25.